Mount Sinai’s Chief Nurse Executive Appointed to the New York Academy of Medicine Board of Trustees
Beth Oliver, DNP, RN, FAAN, Chief Nurse Executive and Senior Vice President, Cardiac Services, Mount Sinai Health System, has been appointed to the New York Academy of Medicine (NYAM)’s Board of Trustees. Dr. Oliver’s appointment was officially ratified by the full Board at a meeting held yesterday at the NYAM followed by a dinner.
Dr. Oliver is the first new Trustee to join NYAM’s board in 2023. NYAM’s Board of Trustees consists of 19 members, who represent various sectors including health care, finance, marketing, business, law, education, and more. Most of NYAM’s board members have backgrounds in health care in some capacity, whether it be clinical care, administration, investment, or other areas. NYAM’s Board of Trustees is responsible for the governance of the organization. In her role as a Trustee, Dr. Oliver will work with the full board to manage and protect NYAM’s best interests.
“I’m honored to be appointed to the New York Academy of Medicine’s Board of Trustees and am proud to represent Mount Sinai and our nurses in this space,” Dr. Oliver said. “I take this responsibility sincerely and look forward to helping create positive change within health systems in our communities.”
As Chief Nurse Executive, Dr. Oliver is responsible for overseeing the practice of nursing and collaborating with the Health System’s senior executive team and the Chief Nursing Officers of Mount Sinai’s eight hospitals. Her top priorities include ensuring the safety and quality of care for patients, supporting and advancing the professional development of nurses, and transforming the care Mount Sinai provides around the needs of patients and communities.
Additionally, as Senior Vice President of Cardiac Services for the Health System, she leads cardiovascular service line strategy and operations while also being responsible for ensuring the delivery of quality care to Mount Sinai Heart patients. Dr. Oliver has also led numerous cardiovascular health-related community outreach programs in partnership with the American Heart Association. In July 2018, Dr. Oliver was appointed President of the American Heart Association’s Board of Directors in New York City, the first nurse to hold the position.
The New York Academy of Medicine has been a public health innovation leader for 176 years. Through research, policy initiatives, a historic library, public programming, partnerships, and programs, NYAM looks to create maximum impact to systems by preventing health inequities and ensuring all communities achieve good health. Programs include the Center for Healthy Aging, Center for Evaluation and Applied Research, Center for Community Partnerships and Policy Solutions, and Center for History of Medicine and Public Health.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.